Chemical Compound

NPoGS

CAS Registry Number 34324-89-5
Back to search Request a Quote
NPoGS chemical structure
Primary Record

NPoGS

In stock
2,223 g
Purity
98.9 %
CAS
34324-89-5

Compound Identifiers & Properties

CAS
34324-89-5
PubChem CID
11542139
SMILES
CCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
Canonical SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCC

Names & Synonyms

  • NPoGS
  • N-PALMITOYL CEREBROSIDE
  • N-Palmitoylpsychosine
  • C16 Galactosylceramide
  • a-Galactosyl-C16-ceramide
  • C16:0-GalCer
  • -galactosyl-c16-ceramide
  • N-Hexadecanoyl cerebroside
  • N-Galactosylpalmytoylceramide
  • 34324-89-5
  • alpha-Galactosyl-C16-ceramide
  • N-Palmitoylgalactosylsphingosine
  • orb2814467
  • GalCer(d18:1/16:0)
  • C40H77NO8
  • CHEBI:83259
  • Galbeta-Cer(d18:1/16:0)
  • DTXSID901120367
  • N-(hexadecanoyl)-beta-D-galactosylsphingosine
  • Galactosylceramide (d18:1/16:0)
  • MFCD00955532
  • ZINC150606831
  • beta-D-galactosyl-N-palmitoylsphingosine
  • CID11542139
  • C16 Galactosylceramide (d18:1/16:0)
  • beta-D-galactosyl-N-hexadecanoylsphingosine
  • N-(palmitoyl)-beta-D-galactosylsphingosine
  • HY-168764
  • J502.164B
  • J775.351I
  • N-(hexadecanoyl)-|A-D-galactosylsphingosine
  • FT-0668937
  • D-erythro-N-Palmitoyl-galactosyl-C18-Sphingosine
  • N-(hexadecanoyl)-1-beta-galactosyl-sphing-4-enine
  • N-Palmitoyl-1-O-beta-D-galactopyranosylsphingosine
  • 1-O-(beta-D-Galactopyranosyl)-N-palmitoylsphingosine
  • 1-O-beta-D-Galactopyranosyl-N-hexadecanoylsphingosine
  • Q27105092
  • beta-D-galactosyl-(1<->1')-N-hexadecanoylsphing-4-enine
  • N-[(2S,3R,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]hexadecanamide
  • Hexadecanamide, N-[(1S,2R,3E)-1-[(beta-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-
  • (2S,3R)-1-(beta-D-Galactopyranosyloxy)-2-(hexadecanoylamino)-4-octadecene-3-ol
  • [(2S,3R)-2-(1-Oxohexadecylamino)-3-hydroxy-4-octadecenyl]beta-D-galactopyranoside
  • [(2S,3R)-2-(Hexadecanoylamino)-3-hydroxy-4-octadecenyl]beta-D-galactopyranoside
  • N-[(1S,2R,3E)-1-(beta-D-Galactopyranosyloxymethyl)-2-hydroxy-3-heptadecenyl]palmitamide
  • N-[(1S,2R,3E)-1-[(beta-D-Galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecenyl]palmitamide
  • Hexadecanamide,N-[(1S,2R,3E)-1-[(beta-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-
  • N-[(1S,2R,3E)-1-[(beta-D-Galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]hexadecanamide
  • N-[(1S,2R,3E)-1-[[(beta-D-Galactopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
  • N-[(2S,3R)-3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide
  • N-[(2S,3R,4E)-3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl]hexadecanamide
  • N-[(E,1S,2R)-2-hydroxy-1-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]heptadec-3-enyl]hexadecanamide
  • N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]hexadecanamide